66504-87-8

Basic information

• Product Name: 3-Azabicyclo[3.1.0]hexane-2,4-dione, 1-(4-methylphenyl)-
• Synonyms: 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane-2,4-dione;(+-)-1-(4-Methylphenyl)-3-azabicyclo[3.1.0]hexan-2,4-dione;3-Azabicyclo[3.1.0]hexane-2,4-dione, 1-(4-methylphenyl)-
• CAS NO: 66504-87-8
• Molecular Formula: C₁₂H₁₁NO₂
• Molecular Weight: 201.22
• Mol File: 66504-87-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Azabicyclo[3.1.0]hexane-2,4-dione, 1-(4-methylphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Azabicyclo[3.1.0]hexane-2,4-dione, 1-(4-methylphenyl)-(66504-87-8)
• EPA Substance Registry System: 3-Azabicyclo[3.1.0]hexane-2,4-dione, 1-(4-methylphenyl)-(66504-87-8)

Safety Data

• Hazardous Substances Data: 66504-87-8(Hazardous Substances Data)

Upstream product

• 66504-83-4 (1R,2S)-1-p-Tolyl-cyclopropane-1,2-dicarboxylic acid 
• 113111-32-3 cis-1-(p-tolyl)-1,2-cyclopropanedicarboxylic acid 
• 66504-76-5 (1R,2S)-1-p-Tolyl-cyclopropane-1,2-dicarboxylic acid dimethyl ester 
• 57-13-6 urea 
• 66504-85-6 (1S,2R)-(-)-1-(4-methylphenyl)-1,2-cyclopropanedicarboxylic acid 
• 77053-52-2 methyl bromo(4-methylphenyl)acetate 
• 622-47-9 4-tolylacetic acid 

Downstream Products

• 71195-57-8 bicifadine 
• 113111-35-6 3-Methyl-1-p-tolyl-3-aza-bicyclo[3.1.0]hexane-2,4-dione 
• 113111-39-0 1-(4-formylphenyl)-3-azabicyclo<3.1.0>hexane-2,4-dione 
• 113111-38-9 1-<4-(hydroxymethyl)phenyl>-3-azabicyclo<3.1.0>hexane-2,4-dione 
• 113111-36-7 1-<4-(bromomethyl)phenyl>-3-azabicyclo<3.1.0>hexane-2,4-dione 
• 113111-37-8 1-(4-Dibromomethyl-phenyl)-3-methyl-3-aza-bicyclo[3.1.0]hexane-2,4-dione 
• 86215-53-4 3-methyl-1-(4-methylphenyl)-3-azabicyclo<3.1.0>hexane 
• 86215-31-8 3-Allyl-1-(p-tolyl)-3-azabicyclo<3.1.0>hexan 
• 86215-19-2 3-Cyclopropylmethyl-1-(p-tolyl)-3-azabicyclo<3.1.0>hexan 
• 66504-75-4 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane hydrochloride 
• 86215-99-8 1-(p-dibromomethylphenyl)-1,2-cyclopropanedicarboximide 
• 83213-67-6 (-)-bicifadine 

Relevant articles and documents

Antipyretic compositions and methods

Methods and compositions containing bicifadine are provided for the treatment and prevention of hyperthermia in mammalian subjects. The methods and compositions may be used to prevent or treat fever, pyresis, menopausal hot flashes; peri menopausal hot fl

METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE

Methods and compositions containing bicifadine are provided for the prevention and treatment of lower urinary tract disorders in mammalian subjects. The methods and compositions may be used to prevent or treat urinary incontinence, urinary urgency, noctur

Polymorphs of bicifadine hydrochloride

A new polymorphic crystalline form of bicifadine hydrochloride, designated form B, which is more thermodynamically stable than the previously known polymorphic form of bicifadine hydrochloride, designated as form A, methods for preparing said crystalline

Method of treating depression using azabicyclohexanes

The present invention concerns certain novel substituted 3-azabicyclo[3.1.0]hexanes and a method of treating depression and stress in a warm-blooded animal, comprising the administration of substituted 3-azabicyclo[3.1.0]hexanes.

1-Aryl-3-azabicyclohexanes, a New Series of Nonnarcotic Analgesic Agents

A series of 1-aryl-3-azabicyclohexanes was synthesized by hydride reduction of 1-arylcyclopropanedicarboximides.Hydroxyphenyl analogues 20, 22, and 24 were prepared by EtSNa-DMF ether cleavage of the corresponding methoxyphenyl analogues 2m, 2n, and 23, respectively, with the secondary amines 20 and 22 going through the N-formyl intermediates 19 and 21.The p-ethoxy analogue 26 was obtained by O-ethylation of 19, followed by base hydrolysis of the amide 25.The greatest analgesic potency in mouse writhing and rat paw-pain assays was observed for para-substituted compounds.Bicifadine, 1-(4-methylphenyl)-3-azabicyclohexane (2b), was the most potent member of the series and is presently undergoing clinical trials in man.Analgesic activity of 2b is limited to the (+) enantiomer 2v, which has the 1R,5S absolute configuration as determined by single-crystal X-ray analysis.The N-methyl analogue (27d) of 2b showed significant analgesic potency, whereas the N-allyl (27a), N-(cyclopropylmethyl) (27b), and N-(n-hexyl) (27c) analogues were inactive.Bicifadine (2b) showed a nonnarcotic profile different from analogous azabicycloalkane and 3-phenylpyrrolidine analgesics.

Process for resolving cis-1-substituted phenyl-1,2-cyclopropanedicarboxylic acids

A method for resolving racemic substituted cyclopropanedicarboxylic acids which are useful as intermediates for the preparation of substituted phenyl azabicyclohexanes which possess anxyolitic and analgesic activity.

Azabicyclohexanes

Substituted 3-azabicyclo[3.1.0]hexanes, acid addition salts, method of use and method of preparation are described. The compounds have anxiolytic and analgesic activity.